Iranian Journal of Child Neurology

How to Cite This Article: Ajami S, Maghsoudlorad AA. The Role of Information Systems to Manage Cerebral Palsy. Iran J Child Neurol.Spring 2016; 10(2): 1-9.

Abstract
Objective
In healthcare system, it is necessary to have exact and accurate information in
order to address health care needs and requirements of society members as well
as expectations of policy makers, planners and decision makers. The aim of this
narrative review article was to explain the role of information systems in cerebral palsy management and identify the advantages and barriers to the development of cerebral palsy registry system. Data were collected using databases such as of Science Direct, PubMed, Proquest, Springer, and SID (Scientific Information Database). Overall, 65 sources were selected. One of the biggest challenges for children with physical and motor disabilities in rehabilitation center is access to a system, which provides a comprehensive data set reflecting all information on a patient’s care. Thus, data and information management in children with physical and motor disability such as cerebral palsy facilitates access to data and cerebral palsy data comparison as well as the monitoring incidence rate of cerebral palsy, enhancing health care quality; however, there are always numerous barriers to establish the system. One of the ways to overcome these problems is the establishment of a standard framework of minimum data sets and exact definition of its data components. Reliable standards in the use of applications as well as user-friendly software will ensure patients’ data extraction and registration.

References

1. Ajami S, Maghsodlorad AA. National Cerebral Palsy Minimum Data Set. Journal of Research in Medical Sciences. J Res Med Sci 2015 Apr;20(4):321-2.
2. Sankar C, Mundkur N. Cerebral palsy-definition, classification, etiology and early diagnosis. Indian J Pediatr 2005 ;72:865-8.
3. Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005;47:571-6.
4. Prudente COM, Barbosa MA, Porto CC. Relation between quality of life of mothers of children with cerebral palsy and the children’s motor functioning, after ten months of rehabilitation. Rev Lat Am Enfermagem 2010;18:149-55.
5. Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 2000;42:816-24.
6. Krägeloh-Mann I, Cans C. Cerebral palsy update. Brain Dev 2009;31:537-44.
7. Stanley FJ, Blair E. Why have we failed to reduce the frequency of cerebral palsy? Med J Aust 1991;154:623-6.
8. Nelson KB, Ellenberg JH. Children who outgrew cerebral palsy. Pediatrics 1982;69:529-36.
9. Reddihough DS, King J, Coleman G, Catanese T. Efficacy of programmes based on Conductive Education for young children with cerebral palsy. Dev Med Child Neurol 1998;40:763-70.
10. Zad Hosseini F, Zarbakhsh MR, Hosseinkhanzadeh AA. Effectiveness of Strengthening Eye-Hand Coordination in Improving Hand Motor Growth in Infants Who Suffer from Cerebral Palsy and are Aged 8-12. J. Basic Appl Sci Res 2013; 3:196-200.
11. Shukla PY, Mann S, Braun SV, Gholve PA. Unilateral hip reconstruction in children with cerebral palsy: predictors for failure. J Pediatr Orthop 2013;33:175-81. doi: 10.1097/BPO.0b013e31827d0b73.
12. Bhatia M, Joseph B. Rehabilitation of cerebral palsy in a developing country: the need for comprehensive assessment. Pediatr Rehabil 2000;4:83-6.
13. Ajami S, Ahmadi G, Etemadifar M. The Role of Information System in Multiple Sclerosis Management. J Res Med Sci 2014; 19(12):1175-84.
14. Nanan DJ, White F. Capture-recapture: reconnaissance of a demographic technique in epidemiology. Chronic Dis Can 1997;18:144-8.
15. Byrne MD, Jordan TR, Welle T. Comparison of manual versus automated data collection method for an evidencebased nursing practice study. Appl Clin Inform 2013;4:61-74. doi: 10.4338/ACI-2012-09-RA-0037.
16. Bali RK. Editor. Clinical knowledge management: opportunities and challenges. Coventry University. UK: IGI Global; 2005.P.200-9.
17. LaTour KM, Maki SE. Health Information Management: Concepts, Principles, and Practice. Third ed. Chicago, USA: American Health Information Management Association; 2010: P. 90-100.
18. Ajami S, Askarianzadeh M, Saghaeiannejad-Isfahani S, Mortazavi M, Ehteshami A. Comparative study on the National Renal Disease Registry (NRDR) in America, England, and Iran. J Educ Health Promot 2014, 3:56.
19. Ajami S, Lamoochi P. Comparative Study on National Burn Registry in America, England, Australia, and Iran. J Educ Health Promot 2014;3:84.
20. Christine C1, Dolk H, Platt MJ, Colver A, Prasauskiene A, Krageloh-Mann I. Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy. Dev Med Child Neurol Suppl 2007;109:35-8.
21. Cans C, Surman G, McManus V, Coghlan D, Hensey O, Johnson A. Cerebral palsy registries. Semin Pediatr Neurol 2004;11:18-23.
22. Carter J, Evans J, Tuttle M, Weida T, White T, Harvell J, et al. Making the Minimum Data Set compliant with health information technology standards. Washington, D.C., USA: U.S. Department of Health and Human Services, Assistant Secretary for Planning and Evaluation Office of Disability, Aging and Long-Term Care Policy 2006:1-58. Available: http://aspe.hhs.gov/daltcp/reports/2006/MDSHIT.htm.
23. Ajami S, Ahmadi G, Saghaeiannejad-Isfahani S, Etemadifar M. A Comparative Study on iMed© and European Database for Multiple Sclerosis to Propose a Common Language of Multiple Sclerosis Data Elements. J Educ Health Promot 2014;3:107.
24. Chilundo B, Sundby J, Aanestad M. Analysing the quality of routine malaria data in Mozambique. Malar J 2004; 3:3.
25. Berg M, Aarts J, Van Der Lei J. ICT in health care: sociotechnical approaches. Methods Inform Med 2003;42:297–301.
26. Pratt W, Unruh K, Civan A, Skeels MM. Communications of the ACM, Personal health information management. CACM 2006;49:51-5.
27. Bakken S, Cashen MS, Mendonca EA, O’Brien A, Zieniewicz J. Representing Nursing Activities within a Concept-oriented Terminological System Evaluation of a Type Definition. J Am Med Inform Assoc 2000;7:81-90.
28. Coenen A, McNeil B, Bakken S, Bickford C, Warren J. Toward comparable nursing data: American Nurses Association criteria for data sets, classification systems, and nomenclatures. Comput Nurs 2000;19:240-6; quiz 6-8.
29. McNeil A, Evans Sue M, Clissold B, Cameron P. Guidelines for the establishment and management of clinical registries. Proceedings of the Australian Commission on Safety and Quality in Health Care. 2009.
30. Davis N, La Cour M. Introduction to Health information technology First version. Philadelphia, USA: Elsevier -Health Sciences Division; 2001.
31. Johns ML. Health information management technology: An applied approach. Chicago, Illinois, Etats-Unis, USA: American Health Information Management Association; 2002:P.250.
32. Goossen WT, Epping PJ, Feuth T, Dassen TW, Hasman A, van den Heuvel WJ. A comparison of nursing minimal data sets. J Am Med Inform Assoc 1998;5:152-63.
33. Abdelhak M, Grostick S, Hanken MA, Jaccobs E. Health information: management of a strategic resource. 2nd ed. Philadelphia: W.B. Saunders;2001: P.155.
34. Werley HH, Devine EC, Zorn CR, Ryan P, Westra BL. The Nursing Minimum Data Set: abstraction tool for standardized, comparable, essential data. Am J Public Health 1991;81:421-6.
35. Ahmadi M, Mohammadi A, Chraghbaigi R, Fathi T, Shojaee Baghini M. Developing a Minimum Data Set of the Information Management System for Orthopedic Injuries in Iran. Iran Red Crescent Med J 2014; 16: e17020.
36. Boyd RN, Jordan R, Pareezer L, Moodie A, Finn C, Luther B, et al. Australian Cerebral Palsy Child Study: protocol of a prospective population based study of motor and brain development of preschool aged children with cerebral palsy. BMC Neurol 2013; 13:57 doi:10.1186/1471-2377-13-57.
37. Uldall P, Michelsen SI, Topp M, Madsen M. The Danish Cerebral Palsy Registry. A registry on a specific impairment. Dan Med Bull 2001;48:161-3.
38. Murphy J. Nursing informatics: the intersection of nursing, computer, and information sciences. Nurs Econ 2010;28:204-7.
39. Guilbert JJ. The world health report 2002 – reducing risks, promoting healthy life. Educ Health (Abingdon) 2003;16:230.
40. Lyons RA, Jones KH, John G, Brooks CJ, Verplancke JP, Ford DV, et al. The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak 2009;9:3.
41. Trojano M. Can databasing optimise patient care? J Neurol 2004;251 Suppl 5:v79-v82.
42. Renner A, Swart J. Patient Core Data Set. Standard for a longitudinal health/medical record. Comput Nurs 1996;15(2 Suppl):S7-13.
43. Molnar GE. Rehabilitation in cerebral palsy. West J Med 1991; 154: 569–572.
44. Anderson B, Hannah KJ. A Canadian nursing minimum data set: a major priority. Can J Nurs Adm 1992;6:7-13.
45. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007;109:8-14.
46. Ajami S, Fatahi M.The role of earthquake information management systems (EIMSs) in reducing destruction: A comparative study of Japan, Turkey and Iran. DPM 2009;18:150-161. doi. 10.1108/09653560910953225.
47. Detmer D, Bloomrosen M, Raymond B, Tang P. Integrated personal health records: transformative tools for consumer-centric care. BMC Med Inform Decis Mak 2008;8:45.
48. Werley HH, Zorn C. The nursing minimum data set: Benefits and implications. In: Proceedings of the 18th NLN Biennial Convention: NLN Publication, 41–2199. ; 1988:105–114.
49. Quinn L, Gordon J. Documentation for Rehabilitation: A Guide to Clinical Decision Making. 2nd ed. USA: Saunders; 2010:p.58.
50. Staltari CF, Baft-Neff A, Marra LJ, Rentschler GJ. Supervision: formative feedback for clinical documentation in a university speech-language pathology program. SIG 11 Perspectives on Administration and Supervision 2010;20:117-23.
51. Ajami S. A Comparative study on Earthquake Information Management Systems (EIMS) in India, Afghanistan and Iran. J Educ Health Promot 2012;1:27-34.
52. Ajami S, Bagheri-Tadi T. Barriers for Adopting Electronic Health Records (EHRs) by Physicians. Acta Inform Med 2013; 21: 129-134.
53. Lober W, Zierler B, Herbaugh A, Shinstrom S, Stolyar A, Kim E, et al., editors. Barriers to the use of a personal health record by an elderly population. Proceeding UAHCI’13 Proceedings of the 7th international conference on Universal Access in Human-Computer Interaction: applications and services for quality of life, AMIA Annu Symp Proc 2006:514-8.
54. Masić I. Use of information technology in the 21st century in the medical sciences. Med Arh 2000;54:59-61.
55. Ajami S, Arab-Chadegani R. Barriers to implement Electronic Health Records (EHRs). Mater Sociomed 2013; 25: 213–215.
56. On ML, Bennett V, Whittaker M. Issues and challenges for health information systems in the Pacific. Pac Health Dialog 2012;18:20-4.
57. Braa J, Hanseth O, Heywood A, Mohammed W, Shaw V. Developing health information systems in developing countries: the flexible standards strategy. MIS Quarterly 2007:381-402.
58. Jacucci E, Shaw V, Braa J. Standardization of health information systems in South Africa: The challenge of local sustainability. Inform Techno Dev 2006;12:225-39.
59. Kaye R, Kokia E, Shalev V, Idar D, Chinitz D. Barriers and success factors in health information technology: A practitioner’s perspective. J Manag Marketing Healthc 2010;3:163-75.
60. Price CP, Kricka LJ. Improving healthcare accessibility through point-of-care technologies. Clin Chem
2007;53:1665-75.
61. Boonstra A, Broekhuis M. Barriers to the acceptance of electronic medical records by physicians from systematic review to taxonomy and interventions. BMC Health Serv Res 2010;10:231.
62. Farah SKS. Bjune GA, Damtew ZA, Abdelaziz AO.Challenges and Opportunities of Integrating Primary Health Care Information System: Northern State, Sudan. Sudanese J Public Health 2011;6:105-109.
63. Mlenzana NB, Frantz JM, Rhoda AJ, Eide AH. Barriers to and facilitators of rehabilitation services for people with physical disabilities: A systematic review. Afr J Disabil 2013;2:6.
64. Hersh W. Health care information technology: progress and barriers. JAMA 2004;292:2273-4.
65. Adel Mehraban M, Hassanpour M, Yazdannik A, Ajami S. Technology User’s Training Is a Waif. Iran Red Cres Med 2013;15:1-7.

How to Cite This Article: Najafi MR, Najafi MA, Safaei A. Association of Family History of Epilepsy with Earlier Age Onset of Juvenile Myoclonic Epilepsy. Iran J Child Neurol. Spring 2016; 10(2):10-15.

Abstract

Objective

Juvenile myoclonic epilepsy (JME) is supposedly the most frequent subtype of idiopathic generalized epilepsies (IGE). The aim of this study was to determine the prevalence of JME and comparison of patients’ demographics as well as timeline of the disease between positive family history epileptic patients (PFHE) and negative family history epileptic patients (NFHE) among sample of Iranian epileptic patients.

Materials & Methods

From Feb. 2006 to Oct. 2009, 1915 definite epileptic patients (873 females) referred to epilepsy clinics in Isfahan, central Iran, were surveyed and among them, 194 JME patients were diagnosed. JME was diagnosed by its specific clinical and EEG criteria. Patients were divided into two groups as PFHE and NFHE and data were compared between them.

Results

JME was responsible for 10% (194 patients) of all types of epilepsies. Of JME patients, 53% were female. In terms of family history of epilepsy, 40% were positive. No significant differences was found between PFHE and NFHE groups as for gender (P>0.05). Age of epilepsy onset was significantly earlier in PFHE patients (15 vs. 22 yr, P<0.001). Occurrence of JME before 18 yr old among PFHE patients was significantly higher (OR=2.356, P=0.007).

Conclusion

A family history of epilepsy might be associated with an earlier age of onset in patients with JME.

References

1. Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy—a review. Epilepsy Res 2009;85(1):31-45.
2. Khedr EM, Shawky OA, Ahmed MA, Elfetoh NA, Al Attar G, Ali AM, et al. A community based epidemiological study of epilepsy in Assiut Governorate/Egypt. Epilepsy Res 2013;103(2):294-302.
3. Rektor I, Schachter SC, Arzy S, Baloyannis SJ, Bazil C, Brázdil M, et al. Epilepsy, behavior, and art (Epilepsy, Brain, and Mind, part 1). Epilepsy Behav 2013;28(2):261-82.
4. Steinlein OK. Genetics and epilepsy. Dialogues Clin Neurosci 2008;10(1):29-38.
5. Engel Jr J. ILAE classification of epilepsy syndromes. Epilepsy Res 2006;70:5-10.
6. Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scandinavica 1985;72(5):449-59.
7. Alfradique I, Vasconcelos MM. Juvenile myoclonic epilepsy. Arquivos de Neuro-Psiquiatria 2007;65(4B):1266-71.
8. Vijai J, Cherian P, Sylaja P, Anand A, Radhakrishnan K. Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands. Seizure 2003;12(7):490-6.
9. Babtain FA. Impact of a family history of epilepsy on the diagnosis of epilepsy in southern Saudi Arabia. Seizure 2013;22(7):542-7.
10. Montenegro MA, Guerreiro MM, Lopes-Cendes I, Guerreiro CA, Li LM, Cendes F, editors. Association of family history of epilepsy with earlier age at seizure onset in patients with focal cortical dysplasia. Mayo Clinic Proceedings 2002;77(12): 1291–94.
11. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, Van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010;51(4):676-85.
12. Janz D. Juvenile myoclonic epilepsy. Epilepsy with impulsive petit mal. Cleveland Clin J Med 1989;56 Suppl Pt 1:S23-33; discussion S40-2. Epub 1989/01/01.
13. Najafi MR, Sonbolestan F, Sonbolestan SA, Zare M, Mehvari J, Meshkati SN. The course and outcome of pregnancy and neonatal situation in epileptic women. Adv Biomed Res 2012;1:4. Epub 2012/12/05.
14. Bittles AH. Consanguinity and its relevance to clinical genetics. Clin Genetics 2001;60(2):89-98.
15. Johnston MV. Nelson’s Textbook of Pediatrics. 17th ed. Seizures in childhood. Vol. 2. Philadelphia: Saunders; 2004 p. 1993–2005.
16. Sinha S, Pramod M, Dilipkumar S, Satishchandra P. Idiopathic generalized epilepsy: Phenotypic and electroencephalographic observations in a large cohort from South India. Ann Indian Academy Neurol 2013;16(2):163.
17. Jallon P, Loiseau P, Loiseau J. Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Epilepsia 2001;42(4):464-75.
18. Oka E, Ishida S, Ohtsuka Y, Ohtahara S. Neuroepidemiological study of childhood epilepsy by application of international classification of epilepsies and epileptic syndromes (ILAE, 1989). Epilepsia 1995;36(7):658-61.
19. Murthy J, Yangala R, Srinivas M. The Syndromic Classification of the International League Against Epilepsy: A Hospital-Based Study from South India. Epilepsia 1998;39(1):48-54.
20. Fittipaldi F, Curra A, Fusco L, Ruggieri S, Manfredi M. EEG discharges on awakening: a marker of idiopathic generalized epilepsy. Neurol 2001;56(1):123-6.
21. Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia 2005;46(s9):10-4.
22. Classification Co, Epilepsy TotILA. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
23. Berkovic, S. F. Genetics of epilepsy syndromes. In: Epilepsy: A Comprehensive Textbook (Eds J. Engel and T. A. Pedley). Lippincott-Raven Publ., 1997: pp. 217–224.
24. Camfield CS, Striano P, Camfield PR. Epidemiology of juvenile myoclonic epilepsy. Epilepsy Behav 2013;28:S15-S7.
25. Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset A population-based study. Neurol 2009;73(13):1041-5.
26. Jayalakshmi SS, Mohandas S, Sailaja S, Borgohain R. Clinical and electroencephalographic study of first-degree relatives and probands with juvenile myoclonic epilepsy. Seizure 2006;15(3):177-83.
27. Sozmen V, Baybas S, Dirican A, Koksal A, Ozturk M. Frequency of epilepsies in family members of patients with different epileptic syndromes. European Neurol 2010;65(1):4-9.
28. Mullins G, O’sullivan S, Neligan A, McCarthy A, McNamara B, Galvin R, et al. A study of idiopathic generalised epilepsy in an Irish population. Seizure 2007;16(3):204-10.
29. Shahnaz KS, Sattar RA. Clinical and EEG characteristics of Juvenile Myoclonic Epilepsy. Pak J Med Sci 2014;30(1):12.
30. Liu A, Delgado-Escueta A, Gee M, Serratosa J, Zhang Q, Alonso M, et al. Juvenile myoclonic epilepsy in chromosome 6p12-p11: Locus heterogeneity and recombinations. Am J Medi Genetics 1996;63(3):438-46.
31. Figueredo R, Trevisol-Bittencourt PC, Ferro JBdM. Estudo clínico-epidemiológico de pacientes com epilepsia mioclônica juvenil em Santa Catarina. Arq Neuropsiquiatr 1999;57(2-B):401-4.
32. Obeid T, Panayiotopoulos C. Juvenile myoclonic epilepsy: a study in Saudi Arabia. Epilepsia 1988;29(3):280-2.
33. Nair RR, Thomas SV. Genetic liability to epilepsy in Kerala State, India. Epilepsy Res 2004;62(2):163-70. 34. Ottman R, Lee JH, Risch N, Hauser WA, Susser M. Clinical indicators of genetic susceptibility to epilepsy. Epilepsia 1996;37(4):353-61.
35. Bianchi A, Viaggi S, Chiossi E. Family study of epilepsy in first degree relatives: data from the Italian Episcreen Study. Seizure 2003;12(4):203-10.
36. Manganotti P, Bongiovanni LG, Fuggetta G, Zanette G, Fiaschi A. Effects of sleep deprivation on cortical excitability in patients affected by juvenile myoclonic epilepsy: a combined transcranial magnetic stimulation and EEG study. J Neurol Neurosurg Psychiatr 2006;77(1):56-60. Epub 2005/12/20.
37. Roebling R, Scheerer N, Uttner I, Gruber O, Kraft E, Lerche H. Evaluation of cognition, structural, and functional MRI in juvenile myoclonic epilepsy. Epilepsia 2009;50(11):2456-65. Epub 2009/06/06.
38. Edwards T, Scott AG, Munyoki G, Odera VMa, Chengo E, Bauni E, et al. Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors. The Lancet Neurol 2008;7(1):50-6.

How to Cite This Article: Fallah E, Arman A, Najafi M, Shayegh B. Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents. Iran J Child Neurol. Spring 2016; 10(2):16-25.

Abstract

Objective

Many studies have supported the role of protein kinase C (PKC) inhibitors in the physiopathology and treatment of bipolar disorder in adults. Tamoxifen is one of the drugs with the effect of PKC inhibition. This study aimed to determine the effect of tamoxifen on the rate of improvement mania symptoms in the sample of children and adolescents with acute mania.

Materials & Methods

In this randomized, placebo-controlled clinical trial study, registered in www.irct.ir with the code of IRCT201410126418N3, overall 44 patients with bipolar disorder with acute manic episode were randomly assigned into treatment and control groups. The serum levels of lithium and tamoxifen among the participants in the treatment groups were 0.8 -1.1 mg and 20-40 mg per day respectively. Serum level of lithium among participants in the control group was similar. The main comparisons were made based on the Young Mania Rating Scale (YMRS) and Children Depression Inventory (CDI) scores of the participants at baseline and at the end of each study week. The pharmacological side effects of serum level of lithium were examined weekly. Analysis of Covariance(ANCOVA) test was used for the statistical analysis.

Results

There was no difference in the baseline score of YMRS and CDI in the treatment and control groups while a statistical significant difference (P < 0.05) in these scores was found between and within the groups.

Conclusion

The addition of tamoxifen to lithium causes a significant difference in reducing the symptoms of mania and depression in the treatment group compared to the control group.

References

1. Manji HK, Lenox RH. Ziskind- Somerfeld Research Award. Protein Kinase C signaling in the brain: Molecular Transduction of mood stabilization in the treatment  of manic-depressive illness. Biol Psychiatry 1999; 46(10):1328-51.
2. Calabrese B, Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 2005; 48(1)77-90.
3. Craske ML, Fiveaz M, Batad NN, Meyer T. Spines and neurite branches function as geometric attractors that enhance protein Kinase C action. J Cell Biol 2005; 170(7): 1147-58.
4. Friedman E, Hoan Yan W, Lewinson D, Connell TA, Singh H, Altered Platelet Protein Kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 1993; 33(7):520-5.
5. Wang Hy, Freidman E. Enhanced Protein Kinase C activity and translation in bipolar affective disorder brain. Biol Psychiatry 1996;40(7)568-75.
6. Einat H, Yuan P, Szaho ST, Dogra S, Manji HK. Protein Kinase C inhibition by tamoxifen antagonizes manic like behavior in rats: Implications for the development of novel therapeutics for bipolar disorders. Neuropsychology 2007: 55(34): 123-31.
7. Harisson-Read PE. Models of mania and antimanic drug actions: Progressing the endophenotype approach. J Psychophar Macol 2008;23(3):334-7.
8. Gimbalvo CT. Protein Kinase C and dopamine transport-2. Effects of amphetamine in Ultro. Neuropharmacology 1992; 31(12): 1211-22.
9. Gimbalor CT. Protein Kinase C and dopamine transport-2. Effects of amphetamine in Ultro. Neuropharmacology 1992; 31(12): 1201-10.
10. Genegy ME, Hong P, Ferell ST. Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Brain Res Mol Brain Res 1993; 20(4): 289-98.
11. Calabrese B, Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 2005; 48(1)77-90.
12. Jordan VC. Molecular mechanisms of anti-estrogen action in breast cancer. Breast Cancer Res Treat 1994; 31(1): 41-52.
13. R. Love R. Effects of tamoxifen on Bone Mineral Density in post-menopausal women with breast cancer. N Engl J Med 1992; 326: 1023-28.
14. National Cancer Institute UNIOH, Tamoxifen: Questions and Answers, 2010; 11.
15. Desmaria J. Interaction between tamoxifen and Antidepressants via Cytochrome P4502D6. J Clin Psychiatr 2009; 20(12):1688-1697.
16. S. Goel S. Effect of Anti-Estrogen on MES and their interaction with Anti-epileptics in Wista- Pats. Pharmacology Online 2009; 1(3):24-30.
17. Geller B, Craneg JL, Bolhofner K, Nickelsburg MJ, Williams M. Phenomenology and Longitudinal course of children with a prepubertal and early adolescent bipolar disorder phenotype. Bipolar disorder in childhood and early adolescence. Guilford 2003:25-50.
18. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Zarate CA, Singh JB, Carlsan PJ, Quiroz J, Jolkovsky L, Luckcu Baugh DA, et al. The Stanley foundation bipolar treatment outcome Network. Demographics and illness characteristics at the first 261 patients. J Affct Disord 2001; 67: 45-59.
19. Smarty S, Find ling RL, Yildiz A, Guleryuz S, Ankerst DP, Ongur D, Renshaw PF. Psychopharmacology of pediatric bipolar disorder: A review. Psychopharmacology 2007; 191: 39-54.
20. Del Bello MP, Findling RL. A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J AM Acad Child Adolesc Psychiatry 2005; 44: 539-47.
21. Gabrielle A, Carlson Stephanie E, Meyer C. Early onset bipolar disorder. Test book of Psychiatry, Kaplan and Sadock, 2009: 3663-3670.
22. Sachs GS, Gardner- Schuster EE. Adjunctive treatment of acute mania: a clinical overview. Acta Psychiatry Scand Suppl 2007; (434): 27-34.
23. Fagiolini A, Chengappa KN. Weight gain and metabolic issues of medicines used for bipolar disorder. Curr Psychiatry Rep 2007; 9(6): 521-8.
24. Manji HK, Zarate CA. Molecular and cellular mechanisms underlying mood stabilizations for the development of improved therapeutics. Mol Psychiatry 2002; 7: 51-7.
25. Manji HK, Bebchuk JM, Moore Gj, Glitz D, HasanatKa, Chen G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: Clin Psychiatry 1999; 60: 27-39.
26. Lawrence SE, Faught KA, Vethamat Y, Lawson ML. Beneficial effects of raloxifen and Tamoxifen in the treatment of Pubertal Gynecomastia. J Pediatr 2004; 145: 71-76.
27. Bebchuk JM, Artkan CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK. A preliminary investigation of a protein Kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 2000; 57(1): 95-7.
28. Gould TD, Einat H. Animal models of bipolar disorder and mood stabilize efficacy: a critical head for Improvement. Neurosci Bio Behave Rev 2007; 31(6): 825-31.
29. Ghanizadeh A, Mohammadi MR. Psychometric properties of the Farsi translation of the Kids, Schedule for Affective Disorders and Schizophrenia. BMC Psychiatry 2006; 6:10.
30. Young Storm EA. Toward and integration of parent and clinical report on the YMRS. J Affect Disord 2003; 77:179-90.
31. Karimi S (2009). normalization, reliability, validity and analysis of Coax Depression Inventory questionnaire in students in Secondary school, MA thesis in psychology, Department of Postgraduate education, Islamic Azad University, Khorasgan Branch.
32. Charles F, Armstrong L, Goldman M, Lance L. Drug information Handbook- Tamoxifen. 2013; 1478-1480.
33. Carlson GA. Meyer SE. Bipolar disorder. Textbook of child and adolescent psychiatry Mina K. Dulcan 2010; 280-295.
34. Eugster EA, Rabin SD, Raiter EO. Tamoxifen treatment for precocious puberty in McCune-Albright Syndrom: A multi-center trial. J Pediatr 2003; 143: 60-66.
35. Neriss C, Kreher, Erica A. Eugster and R. Ravi Shankar A, Pediatrics, 2005; 116; 1513.
36. Lawrence SE, Faught KA, Vethamat Y, Lawson ML. Beneficial effects of raloxifen and Tamoxifen in the treatment of Pubertal Gynecomastia. J Pediatr 2004; 145: 71-76.
37. Walter AW, Gajjar A, Reavdon DA. Tamoxifen and cauhoplutin for children with low grade gliomas: A pilot study at St. Jude Children’s Research Hospital. J Pediatr Hematol Oncol 2000; 22: 247-251.
38. Bebchuk JM, Artkan CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK. A preliminary investigation of a protein Kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 2000; 57(1): 95-7.
39. Kullcarni J, Garaland KA, Scaffidi A, Headey B, Anderson R, Castella de A, et al. A pilot study of hormone modulation as a new treatment for manic in women with bipolar affective disorder. Psych-neuroendocrinology 2006; 31(4): 543-7.
40. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Zarate CA, Singh JB, Carlsan PJ, Quiroz J, Jolkovsky L, Luckcu Baugh DA, et al. Efficacy of a protein kinase C inhibitor (Tamoxifen) in the treatment of acute mania. A pilot study. Bipolar Disorder 2007; (9) (6): 561-70.
41. Smarty S, Find ling RL, Yildiz A, Guleryuz S, Ankerst DP, Ongur D, Renshaw PF. Protein Kinase C inhibition in the treatment of manic: a double blind, Placebo controlled of tamoxifen. Arch Gen Psychiatry 2008; 65(3): 255-63.
42. Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH Maroufi A, Esfandiari G, et al. Efficacy and safety of the Tamoxifen adjunctive to lithium in acute bipolar mania. J Affec Disord 2011; 327-331.
43. Bebchuk JM. A preliminary investigation of a protein Kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiat 2005; 31(4): 543-547.
44. Kelly C, Lee A. Tamoxifen treatment and New-onset depression in Breast cancer patients. Psychosomatics 2007; 48(3): 205-210.

How to Cite This Article: Khosravi Fard E, Keelor JL, Akbarzadeh Bagheban AR, Keith RW. Comparison of the RAVLT and Digit Test with Typically Achieving and Gifted Students. Iran J Child Neurol. Spring 2016; 10(2):26-37.

Abstract

Objective

In this study, different kinds of memory were evaluated using Rey Auditory Verbal Learning (RAVLT) test and were compared between two groups of typical and gifted students using Digit Span test. Finally, we determined if working memory interfered with scores in different Rey stages or not.

Material & Methods

This study was conducted in Tehran City, Iran in 2013. Scores on RAVLT were compared with WISC- R digit span results in a sample of 148 male students aged 12-14 yr old divided into two groups including 75 students in typical school (IQ ranging between 90 and 110) and 73 gifted students (IQs ranging between 110 and 130).

Results

Gifted students obtained higher scores than typical students in both Forward Digit Span (FDS) and Backward Digit Span (BDS) and all 9 stages of RAVLT comparing with typical students (P<0.001). There was no significant difference between different ages (P> 0.05). The 14 yr old students in both groups had the highest score. There was a high correlation between FDS and the first stage of RAVLT as well as high correlation between BDS and seventh stage of RAVLT.

Conclusion

Intelligence has effect on better score of memory and gifted subjects had better scores in memory tests, although the intelligence effect in learning was quantitative rather than qualitative. RAVLT is a comprehensive test, which evaluates short-term memory, working memory and long-term memory and besides Digit span test provides precious information about memory and learning of subjects in order to program different student’s educational schedules.

References

1.C. Gordon Wells. Learning to talk: The pattern of Development. In: C. Gordon Wells, editor. The meaning makers: Children learning language and using language to learn: 1st ed. Heinemann Press 1986.P.22-34.
2.Ackerman PL, Beier ME, Boyle MO. Working memory and intelligence: The same or different constructs? Psychol Bull 2005;131(1):30.
3. Spender J-C. Organizational knowledge, learning and memory: three concepts in search of a theory. JOCM 1996;9(1):63-78.
4. Wechsler D. Intelligence: Definition, theory, and the IQ. In: Robert Cancro, editor. Intelligence: Genetic and environmental influences. Grune and Stratton Press 1971.P. 34-40.
5. Erickson RP. Are Humans the Most Intelligent Species? J Intelligence 2014;2(3):119-21.
6. Salminen T, Strobach T, Schubert T. On the impacts of working memory training on executive functioning. Front Hum Neurosci 2012;6(1); 143-150.
7. Heitz RP, Unsworth N, Engle RW. Working memory capacity, attention control, and fluid intelligence. In: Oliver Wilhelm, Randall W. Engle, editors. Handbook of understanding and measuring intelligence. SAGE Publication. 2005:61-77.
8. Engel de Abreu PM, Conway AR, Gathercole SE. Working memory and fluid intelligence in young children. Intelligence 2010;38(6):552-61.
9. C.D.Woody; Some aspects of information processing in CNS; In: C.D. Woody (Ed.), Memory, learning, and higher function: a cellular view:1982, New York: Plenum Press. pp. 697–710).
10. Yuan K, Steedle J, Shavelson R, Alonzo A, Oppezzo M. Working memory, fluid intelligence, and science learning. ERR 2006;1(2):83-98.
11. Alloway TP, Archibald L. Working memory and learning in children with developmental coordination disorder and specific language impairment. LDX 2008;41(3):251-62.
12. Gathercole SE, Alloway TP. Working Memory and Learning; In: Gathercole SE editor. Working Memory and Learning: A practical guide for teachers. SAGE Publication Limited; 2008.
13. Alloway TP. Working memory, but not IQ, predicts subsequent learning in children with learning difficulties. Europ J Psychol Assess 2009;25(2):92-8.
14. Sternberg RJ. The concept of intelligence and its role in lifelong learning and success. Am Psychol 1997;52(10):1030-1037.
15. Cornoldi C, Orsini A, Cianci L, Giofrè D, Pezzuti L. Intelligence and working memory control: Evidence from the WISC-IV administration to Italian children. Learn Individ Differ 2013; 26:9-14.
16. Conway ARA, Cowan N, Bunting MF, Therriault DJ, Minkoff SRB. A latent variable analysis of working memory capacity, short-term memory capacity, processing speed, and general fluid intelligence. Intelligence 2002;30(2):163-83.
17. Colom R, Abad FJ, Quiroga MÁ, Shih PC, Flores- Mendoza C. Working memory and intelligence are highly related constructs, but why? Intelligence 2008;36(6):584- 606.
18. James W. Montgomery BMM, and Mianisha C. Finney.
Working Memory and Specific Language Impairment: An Update on the Relation and Perspectives on Assessment and Treatment. Am J Speech Lang Pathol 2010;19:78-94.
19. Alloway TP AR. Investigating the predictive roles of working memory and IQ in academic attainment. JEChP. 2010;106:20-9.
20. Matloubi S, Mohammadzadeh A, Jafari Z, Akbarzadeh Baghban A. Effect of background music on auditoryverbal memory performance. Audiology 2014:0-.
21. Jafari ZS, Moritz PH, Zandi T, Akbari Kamrani AA. Malayeri S. Iranian version of the Rey Auditory Verbal Learning Test: a validation study. Arch Clin Neuropsychol 2009;20 (10), 621-628.
22. Esther Strauss, Memory. In: Esther Strauss, Elisabeth M. S. Sherman, Otfried Spreen, editors. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. Oxford University Press. 2006. P.678-891.
23. Talley JL. Memory in learning disabled children: Digit span and the Rey Auditory Verbal Learning Test. Arch Clin Neuropsychol 1986;1(4):315-22.
24. Kyllonen PC, Christal RE. Reasoning ability is (little more than) working-memory capacity?! Intelligence 1990;14(4):389-433.
25. Colom R, Flores-Mendoza C, Quiroga MÁ, Privado J. Working memory and general intelligence: The role of short-term storage. Pers Indiv Differ 2005;39(5):1005-14.
26. Tillman CM, Nyberg L, Bohlin G. Working memory components and intelligence in children. Intelligence 2008;36(5):394-402.
27. Hornung C, Brunner M, Reuter RA, Martin R. Children’s working memory: Its structure and relationship to fluid intelligence. Intelligence 2011;39(4):210-21.
28. Colom R, Quiroga MÁ, Shih PC, Martínez K, Burgaleta M, Martínez-Molina A, et al. Improvement in working memory is not related to increased intelligence scores. Intelligence 2010;38(5):497-505.
29. Bühner M, Kröner S, Ziegler M. Working memory, visual–spatial-intelligence and their relationship to problem-solving. Intelligence 2008;36(6):672-80.
30. Engle RW, Tuholski SW, Laughlin JE, Conway ARA. Working memory, short-term memory, and general fluid intelligence: a latent-variable approach. Clin Neuropsychol 1999;128(3):309.
31. Alloway TP, Gathercole SE, Pickering SJ. Verbal and Visuospatial Short-Term and Working Memory in Children: Are They Separable? Develop Neuropsychol 2006;77(6):1698-716.
32. McMinn MR, Wiens AN, Crossen JR. Rey auditoryverbal learning test: development of norms for healthy young adults. Clin Neuropsychol. 1988;2(1):67-87.
33. Bolla-Wilson K, Bleecker ML. Influence of verbal intelligence, sex, age, and education on the Rey Auditory Verbal Learning Test. Dev Psychol 1986;2(3):203-11.
34. Geffen G, Moar K, O’hanlon A, Clark C, Geffen L. Performance measures of 16–to 86-year-old males and females on the auditory verbal learning test. Clin Neuropsychol 1990;4(1):45-63.
35. Van Der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. Rey’s verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. Arch Clin Neuropsychol 2005;11(3):290-302.
36. Bishop J, Knights RM, Stoddart C. Rey auditory-verbal learning test: Performance of English and French children aged 5 to 16. Arch Clin Neuropsychol 1990;4(2):133-40.
37. van den Burg W, Kingma A. Performance of 225 Dutch school children on Rey’s Auditory Verbal Learning Test (AVLT): parallel test-retest reliabilities with an interval of 3 months and normative data. Arch CliN Neuropsycol 1999;14(6):545-59.
38. Savage RM, Gouvier WD. Rey Auditory-Verbal Learning Test: The effects of age and gender, and norms for delayed recall and story recognition trials. Arch Clin Neuropsycol 1992;7(5):407-14.
39. Sun X, Zhang X, Chen X, Zhang P, Bao M, Zhang D, et al. Age-dependent brain activation during forward and backward digit recall revealed by fMRI. Neuroimage 2005;26(1):36-47.
40. Bleecker ML, Bolla-Wilson K, Agnew J, Meyers DA. Age-related sex differences in verbal memory. J Clin Psychol 1988;44(3):403-11.
41. Hanakawa T HM, Okada T, Fukuyama H, Shibasaki H. Differential activity in the premotor cortex subdivisions in humans during mental calculation and verbal rehearsal tasks: a functional magnetic resonance imaging study. Neurosci Lett 2003, 347(3):199-201.

How to Cite This Article: Salehiomran MR, Nikkhah A, Mahdavi M. Prognosis of Guillain-Barré syndrome in Children. Iran J Child Neurol. Spring 2016; 10(2):38-41.

Abstract

Objective

Guillain-Barre Syndrome (GBS) is an acute polyradiculoneuropathy characterized by progressive motor weakness of limbs and areflexia. In this study, our aim was to evaluate the clinical pattern and prognosis of children with Guillain-Barre syndrome.

Materials & Methods

This cross-sectional study was conducted in the Pediatric Neurology Unit of Amirkola Children’s Hospital, Babol, Iran during the period of 5 years from October 2008 to September 2013. We assessed the clinical features, results of electrodiagnostic tests, functional status, treatment and outcome of 17 children diagnosed with GBS.

Results

Of 17 (male to female ratio = 1.6:1) children studied, all had motor weakness, 4 children (23.5 %) and cranial nerve palsies. Respiratory paralysis was found in one child requiring assisted ventilation. Antecedent illness preceding GBS was recorded in 7 (41.2%) children. The GBS subtype distribution as per electrodiagnostic studies was as follows: acute inflammatory demyelinating  polyradiculoneuropathy (AIDP) in 12 (70.6%) acute motor axonal neuropathy (AMAN) in 3 (17.6%), acute motor sensory axonal neuropathy (AMSAN) in 2 (11.8%). IVIG constituted the treatment given in all of the patients. Complete recovery was observed in 16 children and the remaining one child was dependent to wheelchair.

Conclusion

GBS in children is not poor prognostic disorder and our recommendation is administration of IVIG as soon as possible after clinical diagnosis. Except for one child who remained wheelchair bound, there was no mortality or morbidity in long-term observation. Besides, strong limitation of our study was the low number of subjects.

References

1. Van Doorn PA, Ruts L, Jacobs BC, et al. Guillain-Barre Syndrome: Clinical features, Pathogenesis. Lancet Neurol 2008 Oct; 7(10):939 -50.
2. Dhadke SV, Dhadke VN, Bangar SS, Korade MB. Clinical Profile of Guillain Barre Syndrome. J Asso Physicians India 2013; 61: 168-72.
3. Pi-Lien H, Chang W, Huang L et al. A clinical and electrophysiologic survey of childhood Guillain-Barre syndrome. Pediatr Neurol 2004; 30(2): 86-91.
4. Koul R, Al-Futaisi A, Chacko A et al. Clinical Characteristics of Childhood Guillain-Barré Syndrome. Oman Med J 2008; 23(3): 158–61.
5. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990; 27(suppl): S21-S24.
6. Akbayram S, Doan M, Akgün C, Peker E, Sayın R, Aktar F, et al. Clinical features and prognosis with Guillain- Barré syndrome. Ann Indian Acad Neurol 2011; 14: 98-102.
7. Loeffel VB, Rossi LN, Mumenyhaler M. The Landry Guillain-Barré syndrome complication prognosis and natural history of 123 cases. J Neural SG 1977; 33: 71-79.
8. Maneesh Kumar, Shrikiran Aroor, Suneel Mundkur, Sandeep Kumar. Guillain-Barré Syndrome: A Clinical Study of Twenty Children. J Clin Diagc Res 2015 Jan; 9(1): 9-12.
9. Korinthenberg R, Schulte Monting J. Natural history and treatment effects in Guillain-Barre syndrome: a multicentre study. Arch Dis Child 1996; 74: 281–87.

How to Cite This Article: Rojhani Shirazi M, Tonekaboni SH, Azargashb E, Derakhshannia M, Aghdasta E. Exploring the Psychometric Properties of The Farsi Version of Quality of Life Kindl Questionnaire for 4-7 Year-Old Children in Iran. Iran J Child Neurol. Spring 2016; 10(2):42-52.

Abstract

Objective

The aim of this study was to translate and validate the psychometric properties of the Quality of Life Kindl questionnaire.

Materials & Methods

Parents of 4-7 yr-old healthy and ill children referred to Mofid Children Hospital in Tehran in 2013, Iran were sampled randomly in two groups each of which 130 people. After translation, the questionnaie’s validity and reliability was evaluated and was confirmed for face and content validity. Questionnaire was also completed by two (one healthy and one ill) groups for which inclusion criteria included consent of the parents, age of the children being beween 4 and 7 yr, and presence of the child in a nursery school, kindergarten, school or any class at least for one month. Exclusion criteria were inability of the parents in answering the questions accurately. Inclusion criterion for the ill group was having chronic cardiac, neurologic, hematologic, or respiratory diseases, lasting longer than 3 months for which they were followed up in outpatient clinic in the hospital. The reliability of questionnaire was measured by the Cronbach’s alpha.

Data were analyzed using factor analysis, Spearman’s correlation coefficient, Mann-Whitney and Chi-square test.

Results

The reliability was 0.85 and 0.81 in healthy and ill groups, respectively. The results of factor analysis showed that each of eight subscales of questionnaire had acceptable construct validity. Only two of 52 questions of the questionnaire did not have proper correlation coefficient.

Conclusion

Quality of Life Kindl Questionnaire is a valid and reliable test for assessing healthy and ill children in Iran.

References

1. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL). Development and psychometric properties. Soc Sci Med 1998; 46:1569-1585.
2. Gandek B, Sinclair SJ, Kosinski M, Ware JE Jr. Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financ Rev 2004; 25(4):5-25.
3. DeSalvo KB, Bloser N, Reynolds K, He J, Muntner P. J. Mortality prediction with a single general self-rated health question. A meta-analysis. Gen Intern Med 2006; 21(3):267-75.
4. Conolly MA, & Johnson JA. Measuring quality of life in paediatric patients. Pharmacoeconomics 1999; 16,605–25.
5. Eiser C, Morse R. The measurement of quality of life in children: past and future perspectives. J Dev Behav Pediatr 2001; 22,248 –56.
6. Ravens-Sieberer U, Bullinger M. Manual KINDL-R 2000; Hamburg, Germany. 7. Ravens-Sieberer U. Quality of Life Kindl Questionnaire. Available at: http://kindl.org/cms/information.
8. Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, Lippincott-Raven; 1996.
9. Lovas K, Kalo Z, McKenna SP, Whalley D, Péntek M, Genti G. Establishing a standard for patient-completed instrument adaptations in Eastern Europe: Experience with the Nottingham Health Profile in Hungary. Health Policy 2003; 63(1):49–61.
10. Bullinger M, von Mackensen S, Kirchberger I. KINDL –Ein Fragebogen zur Erfassung der gesundheitsbezogenen Lebensqualität von Kindern. Sonderdruck Zeitschrift für Gesundheitspsychologie 1994; 1:64-77.
11. Asano M, Sugiura T, Miura K, Torii S, Ishiguro A. Reliability and validity of the self-report Quality of Life Questionnaire for Japanese School-age Children with Asthma (JSCA-QOL v.3). Allergy Int 2006; 55(1):59-65.
12. Yaghmaei, F. Designing and measuring the psychometric properties of “Quality of Life scale for the Children suffering from Asthma”. Journal of Shahid Beheshti School of Nursing & Midwifery 2009; 20(68):32-36.
13. El Miedany, YM, Youssef SS, El Gaafary M. Cross cultural adaptation and validation of the Arabic version of the Childhood Health Assessment Questionnaire for measuring functional status in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2003; 21(3):387–393.

How to Cite This Article: Najafi Fard T, Pourmohamadreza-Tajrishi M, Sajedi F, Rezasoltani P, Delavar Kasmaei H. The Effectiveness of Attribution Retraining on Health Enhancement of Epileptic Children. Iran J Child Neurol. Spring 2016; 10(2):53-59.

Abstract

Objective

Epilepsy is a chronic neurological disease. Evidence has indicated that epilepsy has an impact on mental and physical health of children. The present study aimed to determine the effectiveness of attribution retraining on health enhancement of epileptic children.

Materials & Methods

This was an experimental study with a pre-test and a post-test design with a control group. Thirty students with epilepsy (11 female and 19 male students) were selected in convenience from Iranian Epilepsy Association. They were assigned to experimental and control groups and their mothers completed Child Health Questionnaire (CHQ-PF.28) before and after the intervention.

The experimental group attended to eleven sessions (each session 45 minutes; twice a week). Subjects were trained by attribution retraining program, but control group was not. Multivariate analysis of covariance (MANCOVA) was used for analyzing the data.

Results

Health (both psychosocial and physical) of experimental group enhanced significantly after the intervention sessions compared to control group.

Conclusion

Attribution retraining is an effective intervention to enhance the psychosocial and physical health of epileptic children.

References

1. Sadock B, Sadock V, Ruiz P. Comprehensive textbook of psychiatry. Philadelphia: Williams and wilkins. 2009.
2. Walter G, Bradley R. Neurology in clinical practice. B & H Elsevier. 2008; 66:63-74.
3. Baker GA, Hargis E, Hsih MMS, Mounfield H, Arzimanoglou A, Glauser T, et al. Perceived impact of epilepsy in teenagers and young adults: an international survey. Epilepsy Behav 2008; 12(3):395-401.
4. Konda K, Ablah E, Kond K, Liow K. Health behavior and conditions of persons with epilepsy: A bivariate analysis of 2002 Buffs data 2009; 16:120-127.
5. Mushi D, Hunter E, Mtuya C, Mshana G, Aris E, Walker R. Social–cultural aspects of epilepsy in Kilimanjaro Region, Tanzania: knowledge and experience among patients and carers. Epilepsy Behav 2011; 20(2):338-43.
6. Loughin J. College and epilepsy. J Clin Psychiat 2011; 38(3):295-300.
7. Rodenburg R, Wagner JL, Austin JK, Kerr M, Dunn DW. Psychosocial issues for children with epilepsy. Epilepsy Behav 2011; 22(1):47-54.
8. Quintas R, Raggi A, Giovannetti AM, Pagani M, Sabariego C, Cieza A, et al. Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010. Epilepsy Behav 2012; 25(1):60-7.
9. Vázquez C, Jiménez F, Saura F, Avia MD. The importance of “importance”: A longitudinal confirmation of the attributional-stress model of depression measuring the importance of the attributions and the impact of the stressor. Personal Individual Diff 2001; 31(2):205-14.
10. Sepahvand T, Gilani B, Zamani R. Relationship between Attributional Styles with Stressful Life Events and General Health. Psychol Res 2007; 9(3,4): 33-46.
11. Endermann M. Predictors of health-related and global quality of life among young adults with difficult-to-treat epilepsy and mild intellectual disability. Epilepsy Behav 2013; 26(2):188-95.
12. Jackson B, Sellers R, Peterson C. Pessimistic explanatory style moderate the effect of stress on physical illness. Personal Individual Diff 2002; 32:567-73.
13. Seligman ME, Walker EF, Rosenhan DL, Norton W. Abnormal psychology. 4, editor. New York: Norton London; 2001.
14. Schultz D, Schultz S. Theories of personality. Tehran: Virayesh Publication; 2010.
15. Seligman ME. The optimistic child: A proven program to safeguard children against depression and build lifelong resilience. Tehran: Roshd Publication; 2004.
16. Saif A. Modern educational psychology (psychology of learning and instruction). Tehran: Dowran Publishing Company; 2008.
17. Salehi M, Haghighat S. Attribution retraining on student achievement an successful girl. Psychol Res 2008; 1(1):27-39.
18. Rosendal M, Fink P, Bro F, Olesen F. Somatization, heartsink patients, or functional somatic symptoms? Towards a clinical useful classification in primary health care. Scandinavian J Primary Health Care 2005; 23(1):3-10.
19. Larisch A, Schweickhardt A, Wirsching M, Fritzsche K. Psychosocial interventions for somatizing patients by the general practitioner: a randomized controlled trial. J Psychosom Res 2004; 57(6):507-514.
20. Vazehie Ashtiani A. Effect of training documents on attributional style, self-esteem, performance and persistence in mathematics students. J Psychiatr Clin Psychol 2003; 35-87.
21. Qaympnah Z, Azadfallah P, & Tabatabai K. [Psychometric standards and standardization of the Persian version of the Child Health Questionnaire. (Persian)]. Journal of Kermanshah University of Medical Sciences 2013;17(7), 431-441 (In Persian).
22. Ashouri M, Pourmohamadreza-Tajrishi M, Jalil-Abkenar S, & Ashouri J.[The effectiveness of learning strategies and attribution retraining instruction methods on mathematics problem solving in intellectually disabled students (Persian).] Developmental Psychology: Iran Psychol J 2011;8(31), 247-255.
23. Holder EE, Levi DJ. Mental health and locus of control: SCL-90-R and Levenson’s IPC scales. J Clin Psychol 1988; 44(5):753-5.
24. Wang D, Wang Y, Zhang Y. The relationship between locus of control, depression, shame, and self esteem. J Mental Health 1992; 6(5):207-21.
25. Iravani M, Izadi M. Relationship between attribution and mental health in student of Azad University Khorasegan Branch. Knowledge Res Appl Psychol 2000; (1):7-20.
26. Peterson C, Seligman ME. Explanatory style and illness. J Personal 1987; 55(2):237-65.
27. Pourmohamadreza-Tajrishi M, Abbasi S, Najafi Fard T, Yousefi S, Malek Abadi AM, Delavar Kasmaei H. Efficacy of attribution retraining on mental health of epileptic children. Iran Red Cresc Med J 2015; 17(10):1-7.

How to Cite This Article: Fallah R, Habibian S, Noori-Shadkam M. Efficacy and Safety of Single Low Dose Intravenous Fentanyl in Pain Reduction of Lumbar Puncture in Near Term Neonates by A Randomized Clinical Trial. Iran J Child Neurol. Spring 2016; 10(2):60-66.

Abstract

Objective

Reduction of pain of invasive procedures in neonates can prevent pain side effects. The purpose of present study was to evaluate the efficacy and safety of a single low dose of intravenous fentanyl in reducing of lumbar puncture (LP) pain in neonates.

Materials & Methods

In this randomized clinical trial, registered with code number of 2014022616761N150, admitted neonates to Shahid Sadoughi Hospital, Yazd, Iran from August-April 2012 (45 cases) were randomly assigned into two groups to receive 2 μg/kg of intravenous fentanyl or 0.2 milliliter of normal saline, two min before LP. Primary outcome was success rate in reducing of pain during needle insertion to skin (pain score of less than three). Secondary outcomes were clinical side effects and serious adverse events.

Results

Forty-five neonates including 23 girls and 22 boys were evaluated. Pain reduction was obtained in 39.1% (9 of 23 neonates) of fentanyl group and in 4.5% (one of 22 neonates) of control group. Means of pulse rate (136.41± 9.16 vs. 148.9± 8.99) and pain score during needle insertion (3.41±1.31 vs. 5.8±1.12) were lower in fentanyl group. No severe adverse effects were seen in both groups. Side effects such as vomiting [9% (N=2) in control and 4.3% (N=1) in fentanyle group] and mild transient decrease in oxygen saturation in 8.7% (N=2) of fentanyle group were seen. Safety in two groups was not statistically different.

Conclusion

Intravenous fentanyl might be considered as a safe and effective analgesic drug in LP in neonates.

References

1. Lehman RL, Schor NF. Special Diagnostic Procedures. In: Kliegman RM, Stanton BF, Schor NF, St. Geme
2. JW, Behrman RE. Nelson Textbook of Pediatrics. Philadelphia, Saunders 2011; 19th edition, Pp: 2013-2017.
3. Sacchetti A, Baren J, Carraccio C. Total procedural requirements as indication for emergency department sedation. Pediatr Emerg Care 2010;26(3):209-11.
4. Leroy PL, Gorzeman MP, Sury MR. Procedural sedation and analgesia in children by non-anesthesiologists in an emergency department. Minerva Pediatr 2009;61(2):193-215.
5. Gorchynski J, McLaughlin T. The routine utilization of procedural pain management for pediatric lumbar punctures: are we there yet? J Clin Med Res 2011 June 26;3(4):164-7.
6. Maurizi P, Russo I, Rizzo D, Chiaretti A, Coccia P, Attinà G, Ruggiero A, Riccardi R. Safe lumbar puncture under analgo-sedation in children with acute lymphoblastic leukemia. Int J Clin Oncol 2014;19(1):173-7.
7. Pedersen RS, Bayat A, Steen NP, Jacobsson ML.Nitrous oxide provides safe and effective analgesia for minor paediatric procedures--a systematic review. Dan Med J 2013;60(6): A4627.
8. Derakhshanfar H, Modanlookordi M, Amini A, Shahrami A. A comparative study of the sedative effect of oral midazolam and oral promethazine medication in lumbar puncture. Iran J Child Neurol 2013;7(2):11-6.
9. Anghelescu DL, Burgoyne LL, Faughnan LG, Hankins GM, Smeltzer MP, Pui CH. Prospective randomized crossover evaluation of three anesthetic regimens for painful procedures in children with cancer. J Pediatr 2013;162(1):137-41.
10. Fein D, Avner JR, Khine H. Pattern of pain management during lumbar puncture in children. Pediatr Emerg Care. 2010;26(5):357-60.
11. Anand KJ1, Aranda JV, Berde CB, Buckman S, Capparelli EV, Carlo W, Hummel P, Johnston CC, Lantos J, Tutag-Lehr V, Lynn AM, Maxwell LG, Oberlander TF, Raju TN, Soriano SG, Taddio A, Walco GA. Summary proceedings from the neonatal pain-control group. Pediatrics 2006; 117(3 Pt 2):S9-S22.
12. Grunau RE, Holsti L, Haley DW, Oberlander T, Weinberg J, Solimano A, Whitfield MF, Fitzgerald C, Yu W. Neonatal procedural pain exposure predicts lower cortisol and behavioral reactivity in preterm infants in the NICU. Pain 2005; 113(3):293-300.
13. American Academy of Pediatrics Committee on Fetus and Newborn; American Academy of Pediatrics Section on Surgery; Canadian Paediatric Society Fetusand Newborn Committee, Batton DG, Barrington KJ, Wallman C. Prevention and management of pain in the neonate: an update. Pediatrics 2006;118(5):2231-41.
14. Schmidt B, Adelmann C, Stützer H, Welzing L, Hünseler C, Kribs A, Roth B. Comparison of sufentanil versus fentanyl in ventilated term neonates. Klin Padiatr 2010;222(2):62-6.
15. Anand KJ, Willson DF, Berger J, Harrison R, Meert KL, Zimmerman J, et al. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics 2010;125(5): e1208-25.
16. Lawrence J, Alcock D, McGrath P, Kay J, MacMurray SB, Dulberg C. The development of a tool to assess neonatal pain. Neonatal Netw 1993 ;12(6):59-66.
17. Pedersen RS, Bayat A, Steen NP, Jacobsson ML.Nitrous oxide provides safe and effective analgesia for minor paediatric procedures--a systematic review. Dan Med J 2013; 60(6):A4627.
18. Lago P, Guadagni A, Merazzi D, Ancora G, Bellieni CV, Cavazza A; Pain Study Group of the Italian Society of Neonatology. Pain management in the neonatal intensive care unit: a national survey in Italy. Paediatr Anaesth 2005; 15(11):925-31.
19. Glatstein MM, Zucker-Toledano M, Arik A, Scolnik D, Oren A, Reif S.Incidence of traumatic lumbar puncture: experience of a large, tertiary care pediatric hospital. Clin Pediatr (Phila) 2011;50(11):1005-9.
20. Roberts KD, Leone TA, Edwards WH, Rich WD, Finer NN. Premedication for nonemergent neonatal intubations: a randomized, controlled trial comparing atropine and fentanyl to atropine, fentanyl, and mivacurium. Pediatrics 2006; 118(4):1583-91.
21. Ancora G, Lago P, Garetti E, Pirelli A, Merazzi D, Mastrocola M, Pierantoni L, Faldella G Efficacy and safety of continuous infusion of fentanyl for pain control in preterm newborns on mechanical ventilation. J Pediatr 2013;163(3):645-51.e1.
22. Zier JL, Doescher JS. Seizures temporally associated with nitrous oxide administration for pediatric procedural sedation. J Child Neurol 2010;25(12):1517-20.
23. Anghelescu DL, Burgoyne LL, Faughnan LG, Hankins GM, Smeltzer MP, Pui CH. Prospective randomized crossover evaluation of three anesthetic regimens for painful procedures in children with cancer. J Pediatr 2013;162(1):137-41.
24. Mantadakis E, Katzilakis N, Foundoulaki E, Kalmanti M. Moderate intravenous sedation with fentanyl and midazolam for invasive procedures in children with acute lymphoblastic leukemia. J Pediatr Oncol Nurs 2009;26(4):217-22.
25. Gitto E, Pellegrino S, Manfrida M, Aversa S, Trimarchi G, Barberi I, Reiter RJ. Stress response and procedural pain in the preterm newborn: the role of pharmacological and non-pharmacological treatments. Eur J Pediatr 2012;171(6):927-33.
26. Mireskandari SM, Abulahrar N, Darabi ME, Rahimi I, Haji-Mohamadi F, Movafegh A. Comparison of the effect of fentanyl, sufentanil, alfentanil and remifentanil on cardiovascular response to tracheal intubation in children. Iran J Pediatr 2011; 21(2):173-80.
27. Nouri shadkam M, Lotfi M.H. Effect of low dose venous fentanyl in reducing the pain of lumbar puncture in infants. Acta Medica Iranica 2007; 45(3);189-192.
28. Dewhirst E, Naguib A, Tobias JD. Chest wall rigidity in two infants after low-dose fentanyl administration. Pediatr Emerg Care 2012 ;28(5):465-8.

How to Cite This Article: Sadeghzadeh M, Khoshnevisasl P, Parvaneh M, Mousavinasab N. Early and Late outcome of Premature Newborns with history of NICU Admission at 6 years old in Zanjan, Iran. Iran J Child Neurol. Spring 2016; 10(2):67-73.

Objective

Premature birth is an important factor for mortality and morbidity of neonates. This study was designed to evaluate the outcome of preterm neonates who needed neonatal intensive care (NICU) hospitalization after 6 yr at their entrance to the school.

Materials & Methods

This cross sectional study was conducted on premature neonates consecutively hospitalized in NICU of Valie Asr Hospital (the Academic Pediatric Hospital, Zanjan, Northwestern Iran) from September 2001 to September 2003. All children with a history of prematurity and NICU treatment were evaluated at their entrance to the school. Demographic findings, clinical examinations, IQ test, hearing and visual acuity exams were recorded.

Results

From 179 neonates, 78 (43.6%) survived and were discharged from hospital. Fifty-four of them were available and entered first grade in primary school. Only one case had severe mental retardation. One case had severe retinopathy of prematurity (ROP). Hearing abnormality was not detected in any case. There was no significant relation between IQ score, visual as well as hearing findings and gestational age.

Conclusion

We did not find significant disability in the outcome of surviving infants. This could be explained by the high mortality rate of neonates during hospitalization.

References

1. Fakher M, Shaaban W, Abdel Monein A, Hassan Z, Moustafa Fikry M. Statistical Study of Preterm Infants Admitted to NICU in Fawzy Moaz Hospital For Children. Alex J Pediatr 2005; 19 (1):155-8.
2. Fauth de Araújo B, Zatti H, Madi JM, Coelho MB, Olmi FB, Canabarro CT. Analysis of neonatal morbidity and mortality in late-preterm newborn infants. Jornal de Pediatria 2012 ; 88 (3): 259-266.
3. Stephens BE, Vohr BR. Neurodevelopmental outcome of the premature infant. Pediatr Clin North Am 2009; 56 (3):631-46.
4. Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA, Buzas JS. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012;129 (6): 1019-26.
5. Melamed N, Klinger G, Tenenbaum-Gavish K, Herscovici T, Linder N, Hod M, Yogev Y, Short-term Neonatal Outcome in Low-Risk, Spontaneous, Singleton, Late Preterm Deliveries. Obstetr Gynecol 2009 ; 114 ( 2): 253-260.
6. Larroque B, Ancel PY, Marret S, Marchand L, AndréM, Arnaud C, Pierrat V, RozéJC, Messer J, Thiriez G, Burguet A, Picaud JC, Bréart G, Kaminski M, EPIPAGE Study group. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008; 371(9615): 813.
7. Sajedi F, Vameghi R, Mohseni Bandpei MA, Alizad V, Hemmati Gorgani S, Shahshahani Pour S. Motor developmental delay in 7500 iranian infants: prevalence and risk factors. Iran J Child Neurol 2009; 3(3):43-50.
8. Allen MC. Neurodevelopmental outcomes of preterm infants. Curr Opin Neurol 2008 ;21(2):123-8.
9. Beaino G, Khoshnood B, Kaminski M, Marret S, Pierrat V, Vieux R, Thiriez G, Matis J, Picaud JC, RozéJC, Alberge C, Larroque B, Bréart G, Ancel PY, EPIPAGE Study Group. Predictors of the risk of cognitive deficiency in very preterm infants: the EPIPAGE prospective cohort. Acta Paediatr 2011;100 (3): 370.
10. Mikkola K, Ritari N, Tommiska V, Salokorpi T,Lehtonen L, Tammela O, Pa¨a¨kko¨nen L, Olsen P, Korkman M, Fellman V, for the Finnish ELBW Cohort Study Group. Neurodevelopmental Outcome at 5 Years of Age of a National Cohort of Extremely Low Birth Weight Infants Who Were Born in 1996–1997. Pediatrics 2005;116:1391.
11. Mercier CE, Dunn MS, Ferrelli KR, Howard DB, Soll RF. Neurodevelopmental Outcome of Extremely Low Birth Weight Infants from the Vermont Oxford Network: 1998–2003. Neonatology 2010; 97: 329–338.
12. Neubauer AP, Voss W, Kattner E. Outcome of extremely low birth weight survivors at school age: the influence of perinatal parameters on neurodevelopment. Eur J Pediatr 2008; 167(1):87-95.
13. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126(3):443-56.
14. Khan MR, Maheshwari pK, Shamim H, Ahmed S, Ali SR. Morbidity pattern of sick hospitalized preterm infants in Karachi, Pakistan. J Pak Med Assoc 2012; 62 (4): 386- 388.
15. Navaei F, Aliabady B, Moghtaderi J, Moghtaderi M, Kelishadi R. Early outcome of preterm infants with birth weight of 1500 g or less and gestational age of 30 weeks or less in Isfahan city, Iran. World J Pediatr 2010; 6 ( 3): 228-232.
16. Arafa MA, Alshehri MA, Predictors of neonatal mortality in the intensive care unit in Abha, Saudi Arabia. Saudi Med J 2003; 24 (12): 1374-1376.
17. Atalay D, Salihoğlu Ö, Can E, Beşkardeş A, Hatipoğlu S. Short-Term Outcomes of Very Low Birth Weight Infants Born at a Tertiary Care Hospital, Istanbul, Turkey. Iran J Pediatr 2013; 23(2): 205-211.
18. Mathews TJ, MacDorman MF. Infant Mortality Statistics From the 2007 Period Linked Birth/Infant Death Data Set. National Vital Statistics Reports. 2011;59(6).
19. Natarajan G, Shankaran S, Laptook AR, Pappas A, Bann CM, McDonald SA, et al. Apgar scores at 10 min and outcomes at 6-7 years following hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 2013 ;98(6):F473-9.
20. Tommiska V – Heinonenk Ikonen S – pokelu ML-Renlund M/Virtanen M-fellman V. A national short –term followup study of extremely LBW infants born in Finland in 1996-1997. Pediatrics 2001; 107 (1):1-9.
21. Ahmadpour M, Zahedpasha Y, Khafri S, Pishnamazi N. Short-term outcome of premature neonates admitted to NICU & newborn services at Amirkola children hospital in 2010. IJN 2012; 3( 3,4): 10.
22. Calisici E, Eras Z, Oncel MY, Oguz SS, Gokce IK, Dilmen U. Neurodevelopmental outcomes of premature infants with severe intraventricular hemorrhage. J Matern Fetal Neonatal Med 2014 ; 14:1-6.
23. Santos IS, Matijasevich A, Domingues MR, Barros AJD, Victora CG, Barros FC. Late preterm birth is a risk factor for growth faltering in early childhood: a cohort study; BMC Pediatrics 2009; 9:71.
24. Leversen KT, Sommerfelt K, Rønnestad A, Kaaresen PI, Farstad T, Skranes J, et al. Prediction of neurodevelopmental and sensory outcome at 5 years in Norwegian children born extremely preterm. Pediatrics 2011;127(3):e630.
25. Christian P, Murray-Kolb LE, Tielsch JM, Katz J, LeClerq SC, Khatry SK. Associations between preterm birth, small-for gestational age, and neonatal morbidity and cognitive function among school-age children in Nepal. BMC Pediatrics 2014;14:58.
26. Synnes AR, Anson S, Arkesteijn A, Butt A, Grunau RE, Rogers M, Whitfield MF. School entry age outcomes for infants with birth weight≤800 grams. J Pediatr. 2010;157(6):989.
27. van Baar AL, Vermaas J, Knots E, de Kleine MJ, Soons P. Functioning at school age of moderately preterm children born at 32 to 36 weeks’ gestational age. Pediatrics 2009; 124(1): 251.
28. Johnson S, Fawke J, Hennessy E, Rowell V, Thomas S, Wolke D, Marlow N. Neurodevelopmental disability through 11 years of age in children born before 26 weeks of gestation. Pediatrics 2009;124(2):e249.
29. Kerstjens JM, de Winter AF, Bocca-Tjeertes IF, ten Vergert EM, Reijneveld SA, Bos AF. Developmental delay in moderately preterm-born children at school entry. J Pediatr 2011; 159(1):92.
30. Soleimani F, Kazemnejad A,Vameghi R. Risk factor profiles of adverse neuromotor outcome in infants. Iran J Child Neurol 2010; 4 (4): 25-31.

How to Cite This Article: Najafi R, Hashemipour M, Mostofizadeh N, Ghazavi MR, Nasiri J, Shahsanai A, Famori F, Najafi F, Moafi M. Demographic and Clinical Findings in Pediatric Patients Affected by Organic Acidemia. Iran J Child Neurol. Spring 2016; 10(2): 74-81.

Abstract

Objective

Metabolic disorders, which involve many different organs, can be ascribed to enzyme deficiency or dysfunction and manifest with a wide range of clinical symptoms. This study evaluated some of the demographic and clinical findings in pediatric patients affected by organic acidemia.

Materials & Methods

This cross-sectional study was part of a larger study conducted in patients with metabolic disorders during a period of 7 years from 2007 to 2014 in Isfahan Province, Iran. Our study covered a wide range of cases from newborn infants (one-week old) to adolescents (children up to the age of 17 years). This study evaluated patients’ demographic information, history of disease, developmental and educational status, clinical and general conditions. Phone and in-person interviews were used to gather information.

Results

Out of 5100 patients screened in this study, 392 patients were affected by one of the different metabolic disorders and 167 individuals were diagnosed as organic acidemia. Propionic acidemia/methyl malonic acidemia (PA/MMA) was the most prevalent form of this metabolic disorder. The frequency of consanguinity was 84.7% in the group of patients. The mortality rate was 18.8% in patients with organic academia.

Conclusion

Each of the metabolic diseases, as a separate entity, is rare; nevertheless, in aggregate they have a somewhat high overall prevalence. These diseases result in mental and developmental disorders in the absence of quick diagnosis and initiation of treatment. Furthermore, more mutations should be identified in societies affected by consanguinity. Further research should also be conducted to determine worthwhile and more-efficient screening methods as well as longterm neurological prognosis.

References:

1. Champion MP.An approach to the diagnosis of inherited metabolic disease. Arch Dis Child EducPract Ed 2010; 95:40.
2. D.L. Marsden,Inborn Errors of Metabolism: Classification and Biochemical AspectsEncyclopedia of Human Nutrition (Third Edition), 2013, Pages 1-10
3. Huang X, Yang L Dr, Tong F Dr, Yang R Dr, Zhao Z Prof. Screening for inborn errors of metabolism in high-risk children: a 3-year pilot study in Zhejiang Province, China. BMC Pediatr. Feb 24 2012;12(1):18
4. Waisbren SE. Expanded newborn screening: information and resources for the family physician. Am Fam Physician. Apr 1 2008;77(7):987-94.
5. Kliegman RM, Behrman RE, Genson HB, Stanton BF .,An Approach to Inborn Errors of Metabolism, : Nelson textbook of pediatric19th ed, Philadelphia:Saunders;2011, Chapter 78 ;309-16.
6. Ayelet Erez, Oleg A. Shchelochkov, Sharon E. Plon, Fernando Scaglia, and Brendan Lee The American Journal of Human Genetics April 8, 2011,88; 402–421
7. Disorders of energy metabolism1-Nyhan WL, Ozand PT. Atlas of Metabolic Diseases, 1st ed, Chapman and Hall Medical, London 1998.
8. Fowler B. Genetic defects of folate and cobalamin metabolism. Eur J Pediatr 1998; 157 Suppl 2:S60.
9. Hoffmann GF, Zschocke J. Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J Inherit Metab Dis 1999; 22:381.
10. Hoffmann GF, Gibson KM, Trefz FK, et al. Neurological manifestations of organic acid disorders. Eur J Pediatr 1994; 153:S94.
11. Wappner RS. Biochemical diagnosis of genetic diseases. Pediatr Ann 1993; 22:282.
12. Weiner DL. Metabolic emergencies. In: Textbook of pediatric emergency medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott, Williams and Wilkins, Philadelphia 2006. p.1193.
13. Lindor NM, Karnes PS. Initial assessment of infants and children with suspected inborn errors of metabolism. Mayo Clin Proc 1995; 70:987.
14. Kamboj M. Clinical approach to the diagnoses of inborn errors of metabolism. Pediatr Clin North Am 2008; 55:1113.
15. J. Golbahar, E.A. Al-Jishi, D.D. Altayab, E. Carreon, M. Bakhiet, H. Alkhayyat .Selective newborn screening of inborn error of amino acids, organic acids and fatty acids metabolism in the Kingdom of Bahrain ;Molecular Genetics and Metabolism, Volume 110, Issues 1–2, September–October 2013, Pages 98-101.
16. Carlo Dionisi-Vici , Cristiano Rizzo, Alberto B. Burlina, , Ubaldo Caruso, Gaetano Sabetta , Graziella Uziel, Damiano Abeni, ,Inborn errors of metabolism in the Italian pediatric population: A national retrospective survey , the Italian Metabolic Network Contributing Investigators:J Pediatr 2002;140:321-7.
17. Moacir Wajner a,b , Daniella de Moura Coelho a, Rafaela Ingrassia a, Anderson Büker de Oliveira a, Estela Natacha Brandt Busanello a, Kimiyo Raymond c, etal :Selective screening for organic acidemias by urine organic acid GC–MS analysis in Brazil: Fifteen-year experience:Clinica Chimica Acta 400 (2009) 77–81.
18. It-Koon Tan, FRCPath, Bani Gajra, Maria SF Lim, Study of Inherited Metabolic Disorders in Singapore – 13 Years Experience :Ann Acad Med Singapore 2006;35:804-13.
19. Moammar H, Cheriyan G, Mathew R, Al-Sannaa N. Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983-2008. Ann Saudi Med. 2010; 30:271-7.
20. Nagaraja D, Mamatha SN, De T, Christopher R. Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: study in high-risk Indian population. Clinical biochemistry. 2010; 43(6):581-8.
21. Hendriekje Eggink, Anouk Kuiper, Kathryn J Peall, Maria Fiorella Contarino, Annet M Bosch, Bart Post, Deborah A Siva, Marina AJ Tijssen and Tom J de Koning :Rare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioning Eggink et al. Orphanet Journal of Rare Diseases 2014, 9:177.
22. Han LS, Qiu J, Ye WJ, Gao XL, Wang Y, Gu XF: Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. J Inherit Metab Dis 2007, 30:507-514.
23. Xinwen Huang, Lili Yang, Fan Tong, Rulai Yang and Zhengyan Zhao: Screening for inborn errors of metabolism in high-risk children: a 3-year pilot study in Zhejiang Province, China:Huang et al. BMC Pediatrics 2012, 12:18.
24. Tarun Choudhuri and Sivajee Sengupta .Inborn Error of Metabolism –An Indian Perspective،Int J Hum Genet, 6(1): 89-91 (2006).
25. Elsobky E, Elsayed SM. Extended metabolic screen in sick neonates and children. Egypt J Med Hum Genet. 2004; 5: 1-7.
26. Satwani H, Raza J, Hanai J, Nomachi S. Prevalence of selected disorders of inborn errors of metabolism in suspected cases at a Tertiary Care Hospital in Karachi. JPMA. 2009; 59:815-9.
27. Narges Pishva, Alie Mirzaee, Zohre Karamizade, Shahnaz Pourarian, Fariba Hemmati, Mostajab Razvi, Forough Saki.Selective Screening of High-risk Iranian Patients for the Detection of Inborn Error of Metabolism 14 Iranian Journal of Neonatology 2014; 5(4).
28. A. García-Cazorla, N.I. Wolf, M. Serrano, U. Moog, B. Pérez-Dueñas, P. Póo, M. Pineda, J. Campistol, G.F. Hoffmann, Mental retardation and inborn errors of metabolism, J. Inherit. Metab. Dis. 32 (2009) 597–608.
29. Sitke A, Ulrich D, Peter H, Johannes K, Manfred S, Hartmut S. NMR-Based Screening for Inborn Errors of Metabolism: Initial Results from a Study on Turkish Neonate. JIMD Reports DOI 10.1007/8904_2014_326.
30. Waleed H A, Magdy HB, Mohammed SM, Ibrahim H. Risk factors and birth prevalence of birth defects and inborn errors of metabolism in Al Ahsa, Saudi Arabia. Pan Afr Med J 2011; 8:14.
31. Karimzadeh P, Jafari N, Jabbehdari S, Taghdiri MM, Nemati H, Saket S, Alaee MR, Ghofrani M, Tonakebni SH. Methylmalonic Acidemia: Diagnosis and Neuroimaging Findings of This Neurometabolic Disorder (An Iranian Pediatric Case Series). Iran J Child Neurol 2013 7(3): 63- 66.
32.  Ibarra GI, Fernández LC, Reyes GD, Belmont M L, Guillén LS, Monroy SS et al. Inborn Errors of Intermediary Metabolism in Critically Ill Mexican Newborns. J Inborn Errors Metabol Screening 2014:1–7.
33. Hanna AO. Patterns of inborn errors of metabolism: A 12-year single-center hospital-based study in Libya. Qatar Med J 2013 (2):57-65.
34. Tu W, He J, Dai F, Wang X, Li Y. Impact of inborn errors of metabolism on admission in a neonatal intensive care unit--a prospective cohort study. Indian J Pediatr 2012 Apr;79(4):494-500.

How to Cite This Article: Azadvari M, Emami Razavi SZ, Kazemi Sh. Hereditary Sensory and Autonomic Neuropathy Type IV in 9 Year Old Boy: A Case Report. Iran J Child Neurol. Spring 2016; 10(2):83-85.

Abstract

Objective

The Hereditary Sensory and Autonomic neuropathy (HSAN) is a rare group of neuropathies that affects the Sensory and Autonomic nervous system. The patients do not have the ability of sensing different sensations such as pain and temperature, which tends to lead to different injuries. In addition, due to autonomic involvement, the patients suffer from fluctuation in body temperature periodically and lack of precipitation. HSAN is divided into 5 types according to the age of onset, clinical features, and inheritance. Our case was a 9-yr old boy from cousin parents. He had some developmental delay and history of recurrent fever and convulsion in the first year of his life. Gradually, other symptoms added to patient’ feature such as multiple painless skin ulcers, tooth loss, destruction of toes and fingers. In electrodiagnostic study, we found decreased amplitude of sensory nerves, while the other studies were normal. Laboratory test and imaging studies were also normal. All clinical and paraclinical findings were in favor of HSAN type IV. There is no cure for such patients; as a result, these patients and their families need receiving appropriate education and timely rehabilitation services.

References

1. Labib S, AdnaneBerdai M, Abourazzak S, Hida M, Harandou M. Congenitalinsensitivity to pain with anhydrosis: report of a family case. Pan Afr Med J 2011;9:33.
2. Amato A, Dumitru D. Hereditary Neuropathies. In: Dumitru D, Amato A, Zwarts M, Electrodiagnostic Medicine. 2nd ed. Philadelphia; Hanely&Belfus 2002: 911-914.
3. Yuan J, Matsuura E, Higuchi Y, Hashiguchi A, Nakamura T, Nozuma S, Sakiyama Y, Yoshimura A, Izumo S, Takashima H. Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation. Neurology 2013 Apr 30;80(18):1641-9.
4. Edvardson S, Cinnamon Y, Jalas C, et al. Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol 2012;71:569–572.
5. Verhoeven K, Timmerman V, Mauko B, Pieber TR, De Jonghe P, Auer-GrumbachM.Recent advances in hereditary sensory and autonomic neuropathies. CurrOpinNeurol 2006;19(5):474-80.
6. Axelrod FB, Gold-von Simson G. Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet J Rare Dis 2007;2:39. Review.
7. Sany-Soo Lee, Sung-H Lee, Seol-H Han. Terminal changes in hereditary sensory and autonomic neuropathy. A long term follow-up of a sporadic case. Clinical Neurology and Neurosurgery 2003;105(3): 175-179.
8. Kim W, Guinot A, Marleix S, Chapuis M, Fraisse B, Violas P. Hereditary sensory and autonomic neuropathy type IV and orthopaedic complications. OrthopTraumatolSurg Res 2013;99(7):881-5.
9. Safari A, Khaledi AA, &Vojdani M. Congenital Insensitivity to Pain withAnhidrosis (CIPA): A Case Report. Iran Red Crescent Med J 2011;13(2):134-8.
10. Gharagozlou M, Zandieh F, Tabatabaei P,&ZamaniGh. Congenital Sensory Neuropathy as a differential diagnosis for phagocytic Immunodeficiency. Iran J Allergy Asthma 2006; 5(1): 35-37.
11. Baghdadi T ,Sadeghifar A , Mortazavi S.M.J, &Espandar R . Indifference to pain syndrome in a twelve-year-old boy (case report). Tehran Univ Med J 2007; 65 (4) :87-91.

How to Cite This Article: Ashrafzadeh F, Sadrnabavi A, Akhondian J, Beiraghi Toosi M, Mohammadi MH, Hassanpour K. Angelman Syndrome: A Case Report. Iran J Child Neurol. Spring 2016; 10(2):86-89.

Abstract

Objective

Angelman syndrome (AS) is a neurodevelopmental disorder presented by jerky movement, speech delay and cognitive disability epilepsy as well as dysmorphic features. It occurs due to an expression deletion in 15q11-q13 chromosome. In this article, we present an eight yr boy referred to Pediatrics Neurologic Clinic Mashhad, Iran for speech delay. He had abnormal behavior ataxia unusual laughing facial expression intellectual disability and mandibular prognathism.

Metabolic screening tests and brain MRI were normal. Genetic analysis was pathognomonic for AS.

References

1. Jolleff N, Ryan MM. Communication development in Angelman's syndrome. Arch Dis Child. 1993 Jul;69(1):148-50.
2. Landsman IS, Mitzel HM, Peters SU, Bichell TJ. Are children with Angelman syndrome at high risk for anesthetic complications? Paediatr Anaesth. 2012 Mar;22(3):263-7. doi: 10.1111/j.1460-9592.2011.03661.x. Epub 2011 Aug 1.
3. Bai JL, Qu YJ, Zou LP, Yang XY, Liu LJ, Song F. A novel missense mutation of the ubiquitin protein ligase E3A gene in a patient with Angelman syndrome. Chin Med J (Engl). 2011 Jan;124(1):84-8.
4. Cobben JM, van Hal A, van den Puttelaar-van Hal N, van Dijk FS. [A girl with Angelman syndrome]. Ned Tijdschr Geneeskd. 2014;158(0):A8092. [Article in Dutch]
5. Fiumara A1, Pittalà A, Cocuzza M, Sorge G. Epilepsy in patients with Angelman syndrome. Ital J Pediatr. 2010 Apr 16;36:31. doi: 10.1186/1824-7288-36-31.
6. Giroud M, Daubail B, Khayat N, Chouchane M, Berger E, Muzard E.Angelman Syndrome: A Case Series Assessing Neurological Issues in Adulthood. Eur Neurol. 2014 Nov 29;73(1-2):119-125. [Epub ahead of print]
7. Larson AM, Shinnick JE, Shaaya EA, Thiele EA, Thibert RL. Angelman syndrome in adulthood. Am J Med Genet A. 2014 Nov 26. doi: 10.1002/ajmg.a.36864. [Epub ahead of print]
8. Lewis MW, Brant JO, Kramer JM, Moss JI, Yang TP, Hansen P. Angelman syndrome imprinting center encodes a transcriptional promoter. Proc Natl Acad Sci U S A. 2014 Nov 5. pii: 201411261. [Epub ahead of print]
9. Mertz LG, Christensen R, Vogel I, Hertz JM, Nielsen KB, Grønskov K. Angelman syndrome in Denmark. birth incidence, genetic findings, and age at diagnosis. Am J Med Genet A. 2013 Sep;161A(9):2197-203. doi: 10.1002/ajmg.a.36058. Epub 2013 Aug 2.
10. Veiga MF, Toralles MB. [Neurological manifestation and genetic diagnosis of Angelman, Rett and Fragile-X syndromes]. J Pediatr (Rio J). 2002 Jul;78 Suppl 1:S55-62. [Article in Portuguese]
11. Clayton-Smith J, Laan L. Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet 2003;40: 87–95.
12. Thibert RL, Conant KD, Braun EK, Bruno P, Said RR, Nespeca MP, Thiele EA. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options. Epilepsia. 2009 Nov;50(11):2369-76. doi: 10.1111/j.1528-1167.2009.02108.x. Epub 2009 May 12.
13. Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S, Nicholls RD, Horsthemke B. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet. 1995 Apr;9(4):395-400.
14. Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle RL, Hartemink A. Computational and experimental identification of novel human imprinted genes. Genome Res 2007;17:1723-1730.

How to Cite This Article: Bidaki R, Zarepur E, Akrami M, Nadi Sakhvidi M. Functional Neurological Symptom Disorder: Mismanagement, Misdiagnosis, Chronic Cough Following Sexual Abuse; A Rare Case Report. Iran J Child Neurol. Spring 2016; 10(2):90-92.

Abstract

Objective

Conversion disorder (CD) is a mental disorder in which patient displays neurological symptoms such as blindness, mutism, paralysis and seizure. It starts when our mind converts our mental stress into a physical symptom. A 15-year-old single white female with chronic cough, which had begun 5 months ago, was brought to our clinic. She had no history of hospitalization. His daily cough was without sputum production or fever, rhinorrhea and stopped during sleep. There was no recent exposure to tobacco smoke or a person with a chronic productive cough. Laboratory tests were normal. She had engaged 4 months ago.

Doing sex during engagement is prohibited in her culture but and had anal sex, because of her spouse’s trend. Psychotherapy was done and complete recovery was accomplished.

References

1. Feinstein A. Conversion disorder: advances in our understanding. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2011 May 17;183(8):915-20. PubMed PMID: 21502352. Pubmed Central PMCID: 3091899.
2. Pehlivanturk B, Unal F. Conversion disorder in children and adolescents: a 4-year follow-up study. Journal of psychosomatic research. 2002 Apr;52(4):187-91. PubMed PMID: 11943237.
3. Ozsungur B, Foto-Ozdemir D, Ozusta S, Topcu M, Topaloglu H. Treatment of a severe conversion disorder in a 10-year-old boy: a case study and overview. The Turkish journal of pediatrics. 2012 Jul-Aug;54(4):413-8. PubMed PMID: 23692724.
4. Kozlowska K, Nunn KP, Rose D, Morris A, Ouvrier RA, Varghese J. Conversion disorder in Australian pediatric practice. Journal of the American Academy of Child and Adolescent Psychiatry. 2007 Jan;46(1):68-75. PubMed PMID: 17195731.
5. Singh SP, Lee AS. Conversion disorders in Nottingham: alive, but not kicking. Journal of psychosomatic research. 1997 Oct;43(4):425-30. PubMed PMID: 9330242.
6. Haydour Q, Alahdab F, Farah M, Barrionuevo P, Vertigan AE, Newcombe PA, et al. Management and diagnosis of psychogenic cough, habit cough, and tic cough: a systematic review. Chest. 2014 Aug;146(2):355-72. PubMed PMID: 24833061.
7. Mastrovich JD, Greenberger PA. Psychogenic cough in adults: a report of two cases and review of the literature. Allergy and asthma proceedings : the official journal of regional and state allergy societies. 2002 Jan-Feb;23(1):27-33. PubMed PMID: 11894731.
8. Sobot V, Ivanovic-Kovacevic S, Markovic J, Misic-Pavkov G, Novovic Z. Role of sexual abuse in development of conversion disorder: case report. European review for medical and pharmacological sciences. 2012 Feb;16(2):276-9. PubMed PMID: 22428482.
9. Amirsalari S, Radfar S, Ajallouyean M, Saburi A, Yousefi J, Noohi S, et al. Prevalence of epileptiform discharges in children with sensori-neural hearing loss and behavioral problems compared to their normal hearing peers. Iranian journal of child neurology. 2014 Spring;8(2):29-33. PubMed PMID: 24949048. Pubmed Central PMCID: 4058062.
10. Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. The Journal of clinical psychiatry. 2005 Dec;66(12):1529-34. PubMed PMID: 16401153.
11. Tocchio SL. Treatment of conversion disorder. A clinical and holistic approach. Journal of psychosocial nursing and mental health services. 2009 Aug;47(8):42-9. PubMed PMID: 19681521.